We next used the CXCR4+ luciferase+ SW1417 SC CRC model to assess if the selective CXCR4+ cancer cell killing induced by T22‐GFP‐H6‐FdU treatment in vivo was capable of blocking spheroid formation in vitro. The gene discussed is CXCR4; the disease is colorectal carcinoma.